Editorial. Comments on the involvement of podocytes as a target for treatment of proteinuria and all kinds of renal disease with angiotensin converting enzyme inhibitors and/or angiotensin-receptor blockers. Pressure-dependent elastic distention of glomerular capillaries; Local renin-angiotensin system; Effect of apoptotic cell loss; Barrier function of the slit diaphragm.